Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1999-1-7
|
pubmed:abstractText |
Pamidronate disodium, a bone resorption inhibitor through osteoclast mediation, has been used to treat chronic hypercalcemia secondary to malignancy and chronic renal failure. We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic vitamin D poisoning.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0731-3810
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
719-21
|
pubmed:dateRevised |
2006-3-8
|
pubmed:meshHeading |
pubmed-meshheading:9865241-Aged,
pubmed-meshheading:9865241-Diphosphonates,
pubmed-meshheading:9865241-Female,
pubmed-meshheading:9865241-Humans,
pubmed-meshheading:9865241-Hypercalcemia,
pubmed-meshheading:9865241-Iatrogenic Disease,
pubmed-meshheading:9865241-Overdose,
pubmed-meshheading:9865241-Vitamin D
|
pubmed:year |
1998
|
pubmed:articleTitle |
The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
|
pubmed:affiliation |
Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY 11030, USA. dlee@nshs.edu
|
pubmed:publicationType |
Journal Article,
Case Reports
|